Pharmaceutical major Zydus Lifesciences has announced a major share buyback proposal worth ₹1,100 crore, offering investors an exit opportunity at a premium over the prevailing market price. The move has drawn strong attention from market participants and retail shareholders, especially amid ongoing volatility in the broader equity markets. The company’s board approved the repurchase of...
